Directory
>
Erik Holl
Erik Holl
Managing Director - the Netherlands | The Janssen Pharmaceutical Companies of Johnson & Johnson
New Jersey, United States
Erik Holl
Summary
Erik Holl is an accomplished Managing Director at Johnson & Johnson Innovative Medicine in the Netherlands, with extensive experience in the pharmaceutical industry. His expertise spans business strategy, market access, and cross-functional team leadership, making him a key player in driving product launches and sales effectiveness. Erik has held various senior roles across multiple countries, including the United States and Germany, showcasing his adaptability in dynamic environments. He has a proven track record of leading high-performing teams and developing innovative strategies that align with organizational goals. With a solid educational background in Business Administration from Erasmus University, Erik combines theoretical knowledge with practical experience. His career reflects a commitment to excellence and a passion for improving healthcare outcomes. Erik's multilingual capabilities and international experience further enhance his ability to navigate complex markets. He is a strategic thinker who thrives in challenging situations, always looking for opportunities to innovate and lead.
Erik Holl
Work Experience
Managing Director - the Netherlands at
The Janssen Pharmaceutical Companies of Johnson & Johnson
January 2023 - Present
Managing Director - J&J Innovative Medicine - the Netherlands at
Johnson & Johnson Innovative Medicine
January 2023 - Present
VP, Global Commercial Lead, Solid Tumors Targeted Therapies at
The Janssen Pharmaceutical Companies of Johnson & Johnson
June 2021 - January 2023
Commercial Director Oncology & Hematology at
The Janssen Pharmaceutical Companies of Johnson & Johnson
July 2018 - July 2021
Marketing Director GU-Oncology EMEA at
The Janssen Pharmaceutical Companies of Johnson & Johnson
September 2015 - July 2018
Commercial & Corp Strategy Director - NL at
The Janssen Pharmaceutical Companies of Johnson & Johnson
January 2015 - September 2015
Associate Director (CVTL) Oncology - BeNeLux at
Janssen Pharmaceutical Companies Of Johnson And Johnson
November 2013 - April 2015
Associate Director at
Healthy Solutions
January 2012 - October 2013
Business Manager at
Healthy Solutions
March 2011 - January 2012
Corporate Manager Key Accounts at
Janssen Cilag
October 2009 - February 2011
Brand Manager Fertility portfolio & Cerazette at
Merck
June 2008 - November 2009
Area Sales Manager at
Organon
January 2007 - August 2008
Sales Force Effectiveness Manager (incl 7 mth Sales Rep) at
Organon Labs
September 2005 - January 2007
Area Management Trainee / Global Sales at
Organon International GmbH
October 2002 - August 2005
Intern at
Akzo Nobel N.V.
August 2001 - December 2001
Erik Holl
Education
Erasmus University / Rotterdam School of Management, Mscba
January 1996 - January 2002
Odulphus lyceum Tilburg, Vwo / Gymnasium
January 1990 - January 1996
Frequently Asked Questions about Erik Holl
What is Erik Holl email address?
Erik Holl's primary email address is *****@its.jnj.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Erik Holl work for?
Erik Holl is a Managing Director - the Netherlands at The Janssen Pharmaceutical Companies of Johnson & Johnson, a company specializing in Pharmaceutical & Medicine Manufacturing.
Where Erik Holl graduated from?
Erik Holl holds a degree in Business Administration from Erasmus University / Rotterdam School of Management.
How can I directly contact Erik Holl?
To contact Erik Holl directly, you can use the email address *****@its.jnj.com. Complete contact information is available upon registration with Muraena.
Is Erik Holl an immigrant?
Yes, Erik Holl is an immigrant and currently based in United States
Who is Erik Holl?
Erik Holl is an accomplished Managing Director at Johnson & Johnson Innovative Medicine in the Netherlands, with extensive experience in the pharmaceutical industry. His expertise spans business strategy, market access, and cross-functional team leadership, making him a key player in driving product launches and sales effectiveness. Erik has held various senior roles across multiple countries, including the United States and Germany, showcasing his adaptability in dynamic environments. He has a proven track record of leading high-performing teams and developing innovative strategies that align with organizational goals. With a solid educational background in Business Administration from Erasmus University, Erik combines theoretical knowledge with practical experience. His career reflects a commitment to excellence and a passion for improving healthcare outcomes. Erik's multilingual capabilities and international experience further enhance his ability to navigate complex markets. He is a strategic thinker who thrives in challenging situations, always looking for opportunities to innovate and lead.
Erik`s contact details
*****@its.jnj.com
*****@janssen.com
Colleagues
VP of Innovation and Technology Deployment, Janssen Supply Chain
VP, Disease Area Stronghold Lead, Neurodegeneration
Venture Partner
Director IT
Vice President Clinical Development, Solid Tumor Franchise
CIO & VP of Business Technology
Executive Sales Representative
Vice President, Communications, The Americas
Compound Development Leader
Vice President- Global Neuroscience, Infectious Disease, Vaccines and GPH Regulatory Head